Portfolio company
Cornea Project
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops point-of-care diagnostic devices and molecular biomarker analysis technologies for ophthalmologists to detect corneal diseases like keratoconus and dry eye syndrome.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cornea Sense
This company develops a non-invasive device for eye care professionals to directly measure corneal hydration using terahertz sensing and imaging technology.
Ocuwell
This company develops portable corneal topography systems and diagnostic software for clinicians and opticians to improve global access to eye care.
EyeYon
This company develops synthetic corneal implants and therapeutic contact lenses for patients with corneal diseases, providing alternatives to traditional donor tissue transplants.
StemSight
This company develops stem cell therapies using biomaterials to treat corneal blindness in patients with limbal stem cell deficiency and other eye conditions.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Glakolens
This company develops sensor-embedded contact lenses that provide continuous intraocular pressure monitoring for patients with glaucoma and ocular hypertension.
Character Biosciences
This company develops precision medicines and companion diagnostics for degenerative eye diseases, serving patients and pharmaceutical partners.
